|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
LU88258I2
(https=)
|
1978-12-22 |
1994-02-03 |
|
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
ATE183513T1
(de)
|
1993-06-03 |
1999-09-15 |
Therapeutic Antibodies Inc |
Herstellung von antikörperfragmenten
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
CA2243235C
(en)
|
1996-01-17 |
2010-08-10 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic t lymphocytes (ctl)
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AR021849A1
(es)
*
|
1998-09-30 |
2002-08-07 |
Corixa Corp |
Composiciones y metodos para la inmunoterapia especifica de wt1
|
|
AU6940700A
(en)
*
|
1999-08-26 |
2001-03-19 |
Amy P. N Skubitz |
Peptides capable of modulating the function of cd66 (ceacam) family members
|
|
EP1235848A4
(en)
*
|
1999-12-10 |
2005-02-09 |
Epimmune Inc |
INDUCING CELLULAR IMMUNE RESPONSES TO CARCINOEMBRYONIC ANTIGEN USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
|
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
AU7524601A
(en)
|
2000-06-05 |
2001-12-17 |
Sunol Molecular Corp |
T cell receptor fusions and conjugates and methods of use thereof
|
|
JP2004527210A
(ja)
*
|
2000-08-02 |
2004-09-09 |
ザ ジョンズ ホプキンス ユニバーシティー |
内皮細胞発現パターンの評価法
|
|
US7553939B2
(en)
*
|
2001-06-29 |
2009-06-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
T cell regulatory genes and methods of use thereof
|
|
US20030148321A1
(en)
*
|
2001-08-24 |
2003-08-07 |
Iris Pecker |
Methods and kits for diagnosing and monitoring hematopoietic cancers
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
AU2013205381B2
(en)
*
|
2002-03-19 |
2016-04-14 |
Celldex Therapeutics, Inc. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
AU2003270311A1
(en)
*
|
2002-09-06 |
2004-03-29 |
Mannkind Corporation |
Epitope sequences
|
|
AU2003267401A1
(en)
|
2002-10-02 |
2004-04-23 |
F. Hoffmann-La Roche Ag |
Novel mhc ii associated peptides
|
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
|
PT1558643E
(pt)
|
2002-11-09 |
2009-08-24 |
Immunocore Ltd |
Apresentação de um receptor das células t
|
|
US8039218B2
(en)
*
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
|
WO2004052917A2
(en)
*
|
2002-12-10 |
2004-06-24 |
Epimmune Inc. |
Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
DE602004030172D1
(de)
*
|
2003-03-10 |
2010-12-30 |
Japan Science & Tech Agency |
Verfahren zur Kennzeichnung mesenchymaler Stammzellen unter Verwendung verschiedener Marker
|
|
WO2004106511A1
(ja)
|
2003-05-30 |
2004-12-09 |
Nippon Shinyaku Co., Ltd. |
Ｂｃｌ−２の発現抑制をするオリゴ二本鎖ＲＮＡとそれを含有する医薬組成物
|
|
TW200539890A
(en)
*
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
CN101035561A
(zh)
*
|
2004-03-24 |
2007-09-12 |
特罗斯药品公司 |
作为改善对疫苗的免疫反应的佐剂的组合物和使用方法
|
|
EP1872124A4
(en)
*
|
2005-04-19 |
2008-06-11 |
Prediction Sciences Llc |
DIAGNOSIS MARKET FOR BREAST CANCER TREATMENT AND PROGRESSION AND METHOD OF USE THEREOF
|
|
ATE451618T1
(de)
|
2005-04-20 |
2009-12-15 |
Hoffmann La Roche |
Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika
|
|
ES2367643T3
(es)
*
|
2005-04-26 |
2011-11-07 |
Immatics Biotechnologies Gmbh |
Identificador de un epítopo de linfocitos t presentado por el antígeno hla-a2 y derivado de la proteína del receptor de laminina inmadura del antígeno oncofetal y usos de este.
|
|
WO2007011856A2
(en)
*
|
2005-07-15 |
2007-01-25 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for differential diagnosis of chronic lymphocytic leukemia
|
|
SI1806358T1
(sl)
|
2005-09-05 |
2010-06-30 |
Immatics Biotechnologies Gmbh |
S tumorjem povezani peptidi ki se promiskuitetnovežejo na molekule humanega levkocitnega antigena HLA razreda II
|
|
EP1989224B1
(en)
*
|
2006-02-24 |
2010-10-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Immunogenic peptides and methods of use
|
|
US20130332133A1
(en)
*
|
2006-05-11 |
2013-12-12 |
Ramot At Tel Aviv University Ltd. |
Classification of Protein Sequences and Uses of Classified Proteins
|
|
HUE032379T2
(en)
*
|
2007-07-27 |
2017-09-28 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
|
HRP20150820T1
(xx)
*
|
2007-07-27 |
2015-09-11 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv neuronskih tumora i tumora mozga
|
|
WO2009075883A2
(en)
*
|
2007-12-12 |
2009-06-18 |
University Of Georgia Research Foundation, Inc. |
Glycoprotein cancer biomarker
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
CN101648012A
(zh)
*
|
2008-04-24 |
2010-02-17 |
伊玛提克斯生物技术有限公司 |
结合到人类白细胞抗原(hla)ⅰ类或ⅱ类分子上用作疫苗的肿瘤相关肽新制剂
|
|
WO2010019921A2
(en)
*
|
2008-08-15 |
2010-02-18 |
The Regents Of The University Of California |
Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia
|
|
US20120178111A1
(en)
*
|
2009-09-23 |
2012-07-12 |
Diamandis Eleftherios P |
Methods and compositions for the detection of lung cancers
|
|
GB201004551D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
EP2632955A1
(en)
|
2010-10-26 |
2013-09-04 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
ES2603589T3
(es)
|
2012-11-08 |
2017-02-28 |
F. Hoffmann-La Roche Ag |
Ácidos nucleicos que codifican polipéptidos quiméricos para la identificación sistemática de bibliotecas
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
GB201319446D0
(en)
*
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
JP6432114B2
(ja)
*
|
2014-12-25 |
2018-12-05 |
有限会社イムノ |
免疫応答を誘導するための薬剤
|
|
GB201504502D0
(en)
*
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201511546D0
(en)
*
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
CA2995103A1
(en)
*
|
2015-08-07 |
2017-02-16 |
University Of Virginia Patent Foundation |
Identification of class i mhc associated glycopeptides as targets for cancer immunotherapy
|
|
US10335471B2
(en)
*
|
2015-08-28 |
2019-07-02 |
Immatics Biotechnologies Gmbh |
Method for treating cancer with activated T cells
|
|
GB201604492D0
(en)
*
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
WO2018189148A1
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
BR112019020959A2
(pt)
*
|
2017-04-10 |
2020-05-05 |
Immatics Biotechnologies Gmbh |
peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
|
|
US10925947B2
(en)
*
|
2018-06-29 |
2021-02-23 |
Immatics Biotechnologies Gmbh |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
|
|
TW202024121A
(zh)
|
2018-09-18 |
2020-07-01 |
德商英麥提克生物技術股份有限公司 |
A*01 限制肽和肽組合物在抗癌免疫治療中的用途和相關方法
|